Safety and tolerability of the combination therapy with pegylated interferon alfa-2a (Pegasys) and ribavirin (Copegus) in patients with chronic hepatitis C in Poland - interim analysis of data from EAP program. - Andrzej Horban, Marek Beniowski, Hanna Berak, Beata Bolewska, Anna Boroń-Kaczmarska, Janusz Cianciara, Andrzej Cieśla, Jacek Gąsiorowski, Andrzej Gietka, Ewa Gliwińska, Andrzej Gładysz, Zbigniew Gonciarz, Waldemar Halota, Małgorzata Inglot, Urszula Janas-Skulina - Dissemin

Dissemin is shutting down on January 1st, 2025

Language
Login

Links

ORCID

Tools

Export citation

Search in Google Scholar

Safety and tolerability of the combination therapy with pegylated interferon alfa-2a (Pegasys) and ribavirin (Copegus) in patients with chronic hepatitis C in Poland - interim analysis of data from EAP program.

Journal article published in 2004 by Andrzej Horban, Marek Beniowski, Hanna Berak, Beata Bolewska, Anna Boroń-Kaczmarska, Janusz Cianciara, Andrzej Cieśla, Jacek Gąsiorowski, Andrzej Gietka, Ewa Gliwińska, Andrzej Gładysz, Zbigniew Gonciarz, Waldemar Halota, Małgorzata Inglot, Urszula Janas-Skulina and other authors.

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Question mark in circle

Preprint: policy unknown

Upload

Question mark in circle

Postprint: policy unknown

Upload

Question mark in circle

Published version: policy unknown

Upload